Cargando…
Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine
Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen; with the latter generally n...
Autores principales: | Park, Wook-Jin, Yoon, Yeon-Kyung, Park, Ji-Sun, Pansuriya, Ruchirkumar, Seok, Yeong-Jae, Ganapathy, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586335/ https://www.ncbi.nlm.nih.gov/pubmed/34764353 http://dx.doi.org/10.1038/s41598-021-01549-z |
Ejemplares similares
-
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana
por: Malm, Maria, et al.
Publicado: (2019) -
Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
por: Luo, Guoxing, et al.
Publicado: (2022) -
Rotavirus Spike Protein VP4 Mediates Viroplasm Assembly by Association to Actin Filaments
por: Vetter, Janine, et al.
Publicado: (2022) -
Vaccinomics Approach for Multi-Epitope Vaccine Design against Group A Rotavirus Using VP4 and VP7 Proteins
por: Usman, Muhammad, et al.
Publicado: (2023) -
Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice
por: Feng, Hao, et al.
Publicado: (2017)